2016年3月24日

Success Stories: EB-1A Petition Approved for Postdoctoral Scholar in South Carolina in the Field of Cellular Biology

Client’s Testimonial:

“Thank you very, very much. That is great news.”

On January 20th, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Scholar in the Field of Cellular Biology (Approval Notice).

General Field: Cellular Biology
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: South Carolina
Approval Notice Date: January 20th, 2016
Processing Time: 9 days (Premium Processing requested)



Case Summary:
A postdoctoral scholar from India recently reached out to North America Immigration Law Group (WeGreened.com) for help putting together an EB-1A (Alien of Extraordinary Ability) petition. Our team worked diligently to prove the relevance of our client’s research to the United States. We demonstrated that his M.Sc. in Genetics and Ph.D. in Life Science have equipped him for a career in the field of cellular biology, and we detailed his many research studies on protein regulation at the cellular level to accelerate drug development.
Our comprehensive petition packet also accounted for his 138 independent citations, his extensive peer review contributions, and his 8 published articles. We argued that his work is of value not only to the country’s pharmaceutical industry, but also to the health of all Americans. We further strengthened our client’s EB-1A case by compiling several letters of support contributed by other influential cellular biologists. These letters were included in the I-140 petition and played a part in obtaining the USCIS’ approval. One such letter read in part,“[Client’s] continued work is of great importance to the U.S., as it has and will continue to further our understanding in areas such as ceramide applications for cancer treatment and proteomics. This directly benefits molecular biology research in general and cancer research at the molecular level in particular, both of which are vital to the scientific and medical interests of the U.S.”    
As our client opted to file his EB-1A petition under Premium Processing, he received his approval notice merely nine days later. He recently submitted I-485 applications (the last step to a green card) for himself and his wife. We wish them both the best.


We are pleased to announce that North America Immigration Law Group has so far received over 3,500 EB-1A,EB-1B and EB-2 NIW approval notices. In 2014 and 2015, the approval rate is 98.22% for cases using our "Approval or Refund®" (money back guarantee) service and 96.95% for all kinds of services.
For NIW cases, the approval rate is 99.18% for cases using our "Approval or Refund®" (money back guarantee) service and the overall approval rate for all NIW cases is 98.47%.
For EB1A cases, the approval rate is 97.25% for "Approval or Refund®" (money back guarantee) service and the overall approval rate for all EB1A cases is 95.27%.
We are one of the leading U.S. immigration law firms providing the most comprehensive services for EB-1/NIWpetition with a large volume of approval cases and high approval rate.
Our staff keeps close track of the latest immigration trends and regulations of USCIS (U.S. Citizenship and Immigration Services), decisions of AAO (Administrative Appeal Office) and judicial review opinions. The massive collected materials contribute to the most convincing arguments and winning strategies of our firm for EB1A,EB1B, and NIW petitions.
If you are interested in filing the green card, please send your CV to law@wegreened.com for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.

Success Stories: http://blog.wegreened.com/
Free evaluation email: law@wegreened.com
Tel: 888.666.0969 (Toll Free)

To see more clients’ testimonials and approvals, please refer to:

To Learn More About Your Options CLICK HERE


Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.